Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
R-Biopharm Inc. serves as the vital US presence for the globally recognised R-Biopharm AG, operating within the crucial Testing Laboratories industry. Its significant US operations are anchored by Trilogy Analytical Laboratory, Inc., based in Washington, Missouri. Founded in 1999, Trilogy became a key component of the R-Biopharm Group in 2012, strengthening R-Biopharm's capability in North America.
This US entity specialises in comprehensive analytical testing services for the food, feed, and agricultural sectors. Offering both rapid and conventional methods, their core services provide critical analysis for mycotoxins, pesticides, allergens, GMOs, nutritional profiles, and microbiology. R-Biopharm Inc., through Trilogy, is renowned for delivering accurate, reliable, and timely results, upholding stringent food safety and quality assurance standards for clients across the continent.
18
DitchCarbon score
-6 vs industry average
R-Biopharm Inc.’s score of 18 is lower than 47% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at R-Biopharm Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Testing Laboratories has below-average carbon intensity
Industry performance
0.250
20182025
The Testing Laboratories industry has reduced its overall emissions by 27% since 2018
Reported emissions
No reported emissions data is available for R-Biopharm Inc. yet.
R-Biopharm Inc.'s reported carbon emissions
R-Biopharm Inc., a US-based testing laboratory, does not currently have publicly available carbon emissions data. This information is not inherited from any parent organisation. The company has not disclosed specific reduction targets or climate commitments.
Assessing R-Biopharm Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for R-Biopharm Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
R-Biopharm Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for R-Biopharm Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
R-Biopharm Inc.1 month ago
18
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more